Merck KGAa
-
Artificial Intelligence, BioPharma
Merck KGaA Expands in AI-Driven R&D With Two Drug Discovery Deals
Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.
-
Merck KGaA opens Shanghai innovation hub, pumps $14M into China seed fund
Another innovation hub, in the southern city of Guangzhou, is planned for November. To date, six startups in China and other Asian countries have taken part in the German drugmaker’s accelerator program.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Three PD-L1 inhibitors see setbacks in their development
Two drugs – Pfizer and Merck KGaA’s Bavencio and AstraZeneca’s Imfinzi – saw Phase III trials fail, while anticipated negative results prompted Roche to withdraw Tecentriq from regulatory review.
-
Big data and big pharma giants join forces on cancer research effort
Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.
-
Merck KGaA adopts Medisafe medication adherence tool for patients with chronic conditions
As part of the collaboration. Medisafe’s digital health tool will be used for Merck KGaA’s drugs spanning Type 2 diabetes, thyroid disorders, and cardiovascular diseases.
-
Morning Read: Merck KGaA’s oncology revolution, a litmus test on biotech IPOs
Blogging will be light today on MedCity News – most of the staff is off for the Columbus Day holiday.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
